RET and multiple endocrine neoplasia type 2A: Additionally, mutations that trigger RET activity led to multiple endocrine neoplasia type 2A and 2B (MEN2A and MEN2B) and familial medullary thyroid carcinoma (FMTC) thyroid cancers (Vidal et al., 2005).